No evidence that genetic predictors of susceptibility predict changes in core outcomes in JIA.

Objectives: The clinical progression of JIA is unpredictable. Knowing who will develop severe disease could facilitate rapid intensification of therapies. We use genetic variants conferring susceptibility to JIA to predict disease outcome measures.